Pfizer COVID-19 vaccine appointments are available to our patients. Sign up for Connect today to schedule your vaccination.
Joint Clinical Trials Office
BP1001 in Combination with Low-dose Cytarabine (LDAC) in Patients with Previously Untreated (AML) Who Are Ineligible for Induction Therapy
Study Status:
Open to Enrollment
Primary Investigator:
Gail J. Roboz, M.D.
Date: April 21, 2017
Characterization of the Microbiome to Predict Complications in Chronic Kidney Disease and End Stage Kidney Disease Patients
Study Status:
Open to Enrollment
Primary Investigator:
John Richard Lee, M.D.
Date: April 21, 2017
Imaging and Pathologic Correlates for Men at Risk of Prostate Cancer
Study Status:
Open to Enrollment
Primary Investigator:
Jim C. Hu, M.D., MPH
Date: February 27, 2017
Pediatric Inflammatory Bowel Disease (IBD) Biobank
Study Status:
Open to Enrollment
Primary Investigator:
Robbyn E. Sockolow, M.D.
Date: January 13, 2017
Research Registry - Idiopathic Pulmonary Fibrosis Prospective Outcomes Registry (IPF-PRO)
Study Status:
Open to Enrollment
Primary Investigator:
Robert J. Kaner, M.D.
Date: January 13, 2017
Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial (CREST-2)
Study Status:
Open to Enrollment
Primary Investigator:
Dana Leifer, M.D.
Date: January 5, 2017
A Pilot Study of Ketogenic Diet and Metformin in Glioblastoma: Feasibility and Metabolic Imaging
Study Status:
Open to Enrollment
Primary Investigator:
Howard Fine, M.D.
Date: August 19, 2016
The Rogosin Institute Homozygous Familial Hypercholesterolemia Repository
Study Status:
Open to Enrollment
Primary Investigator:
Hudgins, Lisa M.D.
Date: April 28, 2016
Autosomal Dominant Polycystic Kidney Disease Data Repository
Study Status:
Open to Enrollment
Primary Investigator:
Blumenfeld, Jon M.D.
Date: April 28, 2016
Repository of Novel Analytes Leading to Autoimmune, Inflammatory, and Diabetic Nephropathies (RENAL AID)
Study Status:
Open to Enrollment
Primary Investigator:
Alan Perlman, M.D.
Date: March 15, 2016